Abstract
Diabetic Macular Edema (DME) is the most common sight-threatening complication of type 2 diabetes. Our goal was to develop an alternative method to optical coherence tomography (OCT) for DME diagnosis by introducing spectral information derived from spontaneous electroretinogram (ERG) signals as a single input or combined with eye fundus. To this end, an observational study was completed (n = 233 participants). Basal ERGs were used to generate scalograms and spectrograms via Wavelet and Fourier transforms, respectively. Using transfer learning, distinct Convolutional Neural Networks (CNN) were trained as classifiers for DME using OCT, scalogram, spectrogram, and fundus images. Input data were randomly split into training and test sets with a proportion of 80 % to 20 %, respectively. The top performers for each input type were selected, OpticNet-71 for OCT and DenseNet-201 for fundus and non-evoked ERG-derived scalograms, to generate a combined model by assigning different weights for each of the selected models. Model validation was performed using a dataset alien to the training phase of the models. None of the models powered by non-evoked ERG-derived input performed well. Metrics of the best hybrid models were all above 0.81 for fundus combined with non-evoked ERG-derived information; and above 0.85 for OCT combined with non-evoked ERG-derived scalogram images. These data show that the spontaneous ERG-based model improves all the performance metrics of the fundus and OCT-based models, with the exception of sensitivity for the OCT model, to predict DME. Combining non-evoked ERG with OCT represents an improvement to the existing OCT-based models, and combining non-evoked ERG with fundus is a reliable and economical alternative for the diagnosis of DME in underserved areas where OCT is unavailable.
Author summary Providing an alternative diagnostic method to those that already exist for diabetic macular edema (DME) that is reliable and physically and economically accessible is needed in places where optical coherence tomography (OCT) is unavailable. In this work, we combined artificial intelligence (AI) classifying techniques with information from a newly introduced signal that can be captured in a non-invasive manner, the spontaneous oscillations of the electroretinogram (ERG). We found that if these signals alone are ineffective in diagnosing DME cases, they improve the performance of AI models based on either eye fundus or OCT in the prediction of DME. We therefore conclude that combining spontaneous ERG with fundus, which is a basic optometric test even in underserved areas, represents a reliable alternative to OCT for the diagnosis of DME. Also, combining OCT with spontaneous ERG signals will help ameliorate the diagnosis of DME.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
J.A.H.C. is a Master student from the Programa de Maestría en Ciencias (Neurobiología), Universidad Nacional Autónoma de México (UNAM) and received a fellowship from the National Council of Science and Technology of Mexico (CONACYT CVU 1146197). This study was supported by the UNAM-DGAPA grant IN205420 (ST), IN212823 (ST), CONACYT 299625 (ST), and CONACYT CF-2019-1759 (ST) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee for human participants of the Mexican Institute of Ophthalmology (IMO), the National Committee of Ethics (reference: CONBIOÉTICA-09-CEI-006-20170306), and the Research Committee at the Asociación Para Evitar la Ceguera (APEC, 17 CI 09 003 142) approved this study. Written informed consent was provided by all subjects. All procedures were done according to the principles of the Helsinki Declaration.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The Python code and documentation for the analysis are available online (https://github.com/Traslational-Visual-Health-Laboratory).
